# Acrotech Biopharma Inc. – FDA Inspection, Jan 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/d8adac73-ddbc-4993-a60b-4ef35c107440
Source feed: FDA_Inspections

> FDA inspection 1195306 of Acrotech Biopharma Inc., January 19, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 314. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195306
- Company Name: Acrotech Biopharma Inc.
- Inspection Date: 2023-01-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1254819 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/f0ec4968-f49d-4d2a-a936-12f0a2711b4b)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gabrielle-j-swain/55f33430-41dc-4fae-bac0-ec6ea340feb6)

Company: https://www.keypedia.com/companies/acrotech-biopharma-inc/3311a997-8df4-4dc6-9137-27367ba84188

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
